Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01572766 · ClinicalTrials.gov registry record · NA

Effect of Assessing Risk for Osteoporosis on Physician and Patient Behaviors

A NA study, sponsored by Duquesne University.

Completed
Registry status
NA
Development phase
90
Enrollment target

NCT01572766 is a NA study that has completed, run by Duquesne University. The registered enrollment target is 90 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01572766, a NA study, has completed, sponsored by Duquesne University.

COMPLETED
Registry status
NA
Development phase
90 participants
Enrollment target

Study Summary

The study seeks to determine the impact of assessing risk for osteoporosis in women on patient and physician behaviors through a pharmacist directed osteoporosis screening program. Women will be offered a heel ultrasound to screen for their bone density and may or may not be asked questions about their risk for bone fracture. Pharmacists will counsel and educate all women on ways to prevent the onset of osteoporosis. Women will be telephoned three months after the screening and asked a series of 10 questions to follow up on decisions made by their physicians or changes made to their health behaviors related to bone health.

Interventions

  • OTHER FRAX Assessment Tool

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2010-02
Est. Completion 2011-02
Phase NA

Sponsor

Duquesne University

21 total trials

What the Registry Record Tells You About NCT01572766

The ClinicalTrials.gov registry entry for NCT01572766 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duquesne University, which has 21 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which FRAX Assessment Tool is the first listed.

NCT01572766 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01572766 about?

NCT01572766 is a clinical study titled "Effect of Assessing Risk for Osteoporosis on Physician and Patient Behaviors". The study seeks to determine the impact of assessing risk for osteoporosis in women on patient and physician behaviors through a pharmacist directed osteoporosis screening program. Women will be offered a heel ultrasound to screen for their bone density and may or may not be asked questions about th...

What is the current status of trial NCT01572766?

This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2010-02. Estimated completion is 2011-02.

What interventions are being tested in trial NCT01572766?

The interventions under investigation include: FRAX Assessment Tool (OTHER).

Who is sponsoring clinical trial NCT01572766?

This trial is sponsored by Duquesne University, which has 21 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.